PhaseV
PhaseV offers AI-driven solutions that enhance clinical development for biopharma sponsors and contract research organizations (CROs). The company focuses on utilizing machine learning to streamline clinical operations, improving the processes of feasibility assessments and site selection. By providing data-driven insights, PhaseV helps clients make informed decisions that accelerate trial timelines. Their innovative approach aims to transform traditional methods in clinical research, contributing to more efficient and effective drug development. With a commitment to integrating technology into clinical trials, PhaseV plays a significant role in advancing the pharmaceutical industry's operational capabilities.
Domain
phasevtrials.com
Country
United StatesIndustry
Artificial Intelligence (AI)Employees
11-50
Last Funding
$50.0M
Founded
2022
Tech Stack (15 technologies)
Frequently Asked Questions
What technologies does PhaseV use?+
PhaseV uses 15 technologies including Google Analytics, Google Tag Manager, jsDelivr.
What industry is PhaseV in?+
PhaseV operates in the Artificial Intelligence (AI) industry.
Where is PhaseV based?+
PhaseV is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026